phase III – CFN Media

Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx™’s Efficacy; Analysts Reiterate Buy Ratings

An incredible amount of planning and preparation goes into the design of…

Robin Lefferts
October 27, 2026

Cardiol Therapeutics: Analysts and Institutions Are In

Ahead of the pivotal Phase III MAVERIC topline results, expected in mid-2027,…

Robin Lefferts
September 24, 2026

How CardiolRx™ Could Fit Into the Recurrent Pericarditis Treatment Regimen

Recurrent pericarditis (RP) is a debilitating disease in need of better forms…

Robin Lefferts
August 11, 2026

Don Kreski

Robin Lefferts

Ryan Allway

Ryan has been a financial writer for more than a decade, covering…

Stella Emory

Wilson Augustine

Tech Stocks

MBody AI Doubles Deployment at Major Northeast Casino & Entertainment Destination

Nasdaq-listed physical AI company grows it’s support at Mohegan Sun’s…

Ryan Allway
November 5, 2026

Graphite One Secures Final Ohio Air Permit, Supporting Further Progress towards Planned Construction for US$80 Million Phase 1 Anode Plant

Ten-year permit covers the planned 10,000-tonne-per-year Phase 1 in Conneaut, Ohio…

Ryan Allway
November 2, 2026

Opportunity: The United States Still Needs A Lot of Domestic Lithium

A few years ago, lithium was the darling of the global investment…

Robin Lefferts
October 29, 2026

Why Investors Should Pay Attention to Lithium Explorers

The lithium carbonate market has been in a bit of a boom/bust…

Ryan Allway
October 27, 2026